Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Gufic BioSciences Ltd

Pharmaceuticals & Biotechnology | Small Cap

Gufic BioSciences Ltd Health Insights
Health Score : 5.49Health Score : 5.49

Gufic BioSciences Ltd demonstrates a mixed financial performance. The company shows strong solvency and profitability, indicating a solid foundation and efficient use of capital. Revenue and asset growth are also positive signs. However, liquidity is a concern, suggesting potential difficulties in meeting short-term obligations. Efficiency ratios are low, which could point to issues with asset utilization. While the company maintains a good dividend coverage, declines in operating profit, EPS, and net income growth raise concerns about future earnings sustainability. Overall, the company's strengths in profitability and solvency are tempered by weaknesses in liquidity and efficiency, requiring careful monitoring of operational performance to ensure long-term stability.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Gufic BioSciences Ltd Health Insights
Health Score : 5.49Health Score : 5.49

Gufic BioSciences Ltd demonstrates a mixed financial performance. The company shows strong solvency and profitability, indicating a solid foundation and efficient use of capital. Revenue and asset growth are also positive signs. However, liquidity is a concern, suggesting potential difficulties in meeting short-term obligations. Efficiency ratios are low, which could point to issues with asset utilization. While the company maintains a good dividend coverage, declines in operating profit, EPS, and net income growth raise concerns about future earnings sustainability. Overall, the company's strengths in profitability and solvency are tempered by weaknesses in liquidity and efficiency, requiring careful monitoring of operational performance to ensure long-term stability.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Neutral

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Neutral

P/E RATIO (TTM)

56.39

Highly Overvalued

Industry Median

28.62

Highly Overvalued
Highly Overvalued

Small Cap Median

27.17

Highly Overvalued

P/E RATIO

55.51

P/B RATIO

5.36

Highly Overvalued

Industry Median

3.17

Highly Overvalued
Highly Overvalued

Small Cap Median

2.62

Highly Overvalued

P/S RATIO

3.83

Neutral

Industry Median

3.42

Neutral
Overvalued

Small Cap Median

2.55

Overvalued

Others

Neutral

PEG RATIO

0.00

Neutral
Overvalued

EV/EBITDA RATIO

23.67

Overvalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹355.25 as on Jun 19, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 4.80

The company's growth ratios present a mixed picture. Strong revenue and asset growth is offset by declines in operating profit, EPS, and net income growth. While the company is expanding its top-line and asset base, profitability is suffering. This suggests potential issues with cost management or pricing strategies. Maintaining revenue and asset growth while improving profitability will be critical for sustainable long-term performance.

ExcellentRevenue Growth RateExcellent
PoorOperating Profit Growth RatePoor
PoorEarnings Per Share (EPS) GrowthPoor
ExcellentAsset Growth RateExcellent
PoorNet Income Growth RatePoor
Growth RatiosMar 2024Mar 2025Mar 2026
Revenue Growth Rate1.6115.12
Operating Profit Growth Rate-9.3311.03
Earnings Per Share (EPS) Growth-19.09-7.91
Asset Growth Rate6.9514.8
Net Income Growth Rate-18.6-8.57
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 3.80

The company's financial ratios present a mixed view. While adjusted EPS is average, cash EPS, book value per share, dividend per share, and capital expenditures are low. This could point to challenges in earnings quality, shareholder value, and investment in future growth. Improving cash earnings, increasing book value, and making strategic capital investments will be important for enhancing overall financial performance and shareholder returns.

AverageAdjusted Earnings Per Share (Adjusted EPS)Average
WeakCash Earnings Per Share (Cash EPS)Weak
WeakBook Value Per ShareWeak
PoorDividend Per Share (DPS)Poor
PoorCapital Expenditures (CapEx)Poor
Financial RatiosMar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)8.876.4
Cash Earnings Per Share (Cash EPS)10.39.19.5
Book Value Per Share53.360.166.5
Dividend Per Share (DPS)0.090.070
Capital Expenditures (CapEx)108.170.831.2
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 9.80

The company demonstrates strong profitability. Excellent margins across gross profit, operating profit, and net profit indicate efficient operations and effective pricing strategies. High returns on capital employed, equity, and assets confirm the company's ability to generate substantial profits from its investments. This robust profitability reflects sound management and a competitive edge in the healthcare services sector.

ExcellentGross Profit MarginExcellent
ExcellentReturn on Capital Employed (ROCE)Excellent
ExcellentReturn on Equity (ROE)Excellent
GoodReturn on Assets (ROA)Good
ExcellentOperating MarginExcellent
ExcellentNet MarginExcellent
Profitability RatiosMar 2024Mar 2025Mar 2026
Gross Profit Margin16.4814.0212.71
Return on Capital Employed (ROCE)18.921312
Return on Equity (ROE)16.1411.659.62
Return on Assets (ROA)13.7211.6311.25
Operating Margin18.5916.5916
Net Margin10.668.546.78
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 2.67

The company's efficiency ratios indicate poor asset utilization. Low turnover ratios for fixed assets, inventory, and receivables suggest that the company is not effectively converting its investments into sales. High days sales in inventory and receivable days further highlight inefficiencies in managing inventory and collecting payments. This suggests a need to streamline operations and improve asset management to enhance overall performance.

PoorFixed Asset Turnover RatioPoor
WeakInventory Turnover RatioWeak
PoorReceivables Turnover RatioPoor
WeakDays Sales in Inventory RatioWeak
PoorReceivable DaysPoor
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio5.081.621.92
Inventory Turnover Ratio3.373.383.05
Receivables Turnover Ratio2.452.543.08
Days Sales in Inventory Ratio108.31107.99119.67
Receivable Days149143.7118.51
Capital Turnover Ratio1.151.081.19
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 8.80

The company exhibits strong coverage ratios. A solid interest coverage ratio indicates a comfortable ability to meet its debt obligations, reducing financial risk. The excellent equity dividend coverage ratio demonstrates a strong capacity to sustain dividend payments to shareholders. These coverage metrics reflect a stable financial position and a commitment to meeting obligations and rewarding investors.

GoodInterest Coverage RatioGood
ExcellentEquity Dividend Coverage RatioExcellent
Coverage RatiosMar 2024Mar 2025Mar 2026
Interest Coverage Ratio7.824.763.35
Equity Dividend Coverage Ratio100100
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 9.50

The company exhibits strong solvency, indicating a solid financial structure. Low debt and high equity ratios suggest a conservative approach to financing, reducing financial risk. The debt-to-asset ratio further supports this, reflecting a substantial asset base relative to debt. This strong solvency provides a stable foundation, enabling the company to pursue long-term growth opportunities with reduced vulnerability to economic downturns.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
GoodEquity RatioGood
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2024Mar 2025Mar 2026
Debt Ratio0.240.210.16
Debt to Equity Ratio0.320.270.19
Equity Ratio0.760.790.84
Debt To Asset Ratio0.160.130.09
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 4.26

The company's liquidity position shows mixed signals. While the quick ratio is average, indicating some ability to meet short-term obligations, the current and operating cash flow ratios suggest potential difficulties in managing immediate liabilities. The low cash ratio is a concern, reflecting limited cash reserves. This blended performance indicates a need for careful management of current assets and liabilities to ensure the company can comfortably meet its short-term obligations.

WeakCurrent RatioWeak
AverageQuick RatioAverage
PoorCash RatioPoor
WeakOperating Cash Flow RatioWeak
Liquidity RatiosMar 2024Mar 2025Mar 2026
Current Ratio1.61.551.5
Quick Ratio1.091.030.91
Cash Ratio0.030.070.14
Operating Cash Flow Ratio-0.020.30.08
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 22 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Jagsonpal Pharmaceuticals Ltd8.5133.01Overvalued58.006.4243.00
2Amrutanjan Health Care Ltd8.2577.37Highly Overvalued31.0020.0321.00
3Windlas Biotech Ltd7.5225.92Neutral105.0032.1966.00
4Innova Captab Ltd7.3638.55Overvalued243.0014.63141.00
5Hikal Ltd7.13-51.71Neutral220.00-3.95-49.00
6RPG Life Sciences Ltd7.1232.70Neutral147.0069.64115.00
7Morepen Laboratories Ltd7.1228.61Neutral126.001.2196.00
8Alembic Ltd7.067.28Undervalued90.004.85317.00
9Syncom Formulations (India) Ltd6.9217.27Undervalued77.000.8176.00
10Sigachi Industries Ltd6.4911.55Highly Undervalued54.00-2.08-83.00
11SMS Pharmaceuticals Ltd5.9434.77Neutral171.009.35102.00
12Gufic BioSciences Ltd5.4955.51Neutral151.006.3064.00
13Dishman Carbogen Amcis Ltd5.3827.45Neutral566.00-2.4597.00
14IOL Chemicals & Pharmaceuticals Ltd5.3127.76Undervalued269.004.69138.00
15Indoco Remedies Ltd5.26-22.79Neutral142.00-0.61-99.00
16Aarti Drugs Ltd5.0717.34Undervalued309.0018.54195.00
17Orchid Pharma Ltd4.85241.74Neutral41.008.9121.00
18Sequent Scientific Ltd4.61293.05Overvalued162.000.6332.00
19Sun Pharma Advanced Research Company Ltd4.354.97Neutral1599.0047.831553.00
20Solara Active Pharma Sciences Ltd4.34-274.68Neutral187.00-1.50-7.00
21Zota Health Care Ltd3.97-61.25Neutral19.008.06-74.00
Management Assessment Summary
OrangeBalanced Management

The management of Gufic BioSciences demonstrates a mixed performance. A strong promoter holding indicates confidence, but declining profit growth and operating profit margins raise concerns. While revenue growth is positive, capital efficiency, as reflected in ROCE and ROE, is moderate. Increasing interest expenses and a declining net profit also present challenges. The company's consistent dividend payout is a positive aspect. Overall, management effectiveness is mixed due to profitability and operational efficiency challenges despite revenue growth.

Category Metric Value Assessment
PROS Promoter Holding 72.51% High promoter confidence and alignment
Dividend Payout 1% Consistent profit sharing
CONS Declining Profit Growth -21% (TTM) Profit growth is declining
Declining OPM 12.87% (Mar 2025 Qtr) Operational efficiency is decreasing
AverageFinancial Performance & GrowthAverage
AverageCapital Efficiency & ReturnsAverage
AverageFinancial Health & PrudenceAverage
AverageStrategic & Operational IndicatorsAverage
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Strategic & Operational Indicators

Risk Assessment Summary
OrangeBalanced Risk

The risk assessment for Gufic BioSciences is rated as Orange due to several factors. The declining profit growth and OPM raise concerns about financial performance. The increase in inventory days and cash conversion cycle indicate potential inefficiencies in working capital management. Additionally, the rise in interest expenses and borrowings could strain financial health. Therefore, while the company exhibits some strengths, these identified risks warrant a cautious approach.

AverageRegulatory compliance cost trendsAverage
01.

Regulatory compliance cost trends

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10356.57Bearish
  3. SMA 20360.37Bearish
  4. SMA 50361.79Bearish
  5. EMA 10356.84Bearish
  6. EMA 20359.14Bearish
  7. EMA 50361.45Bearish
  8. DEMA 10354.32Bearish
  9. DEMA 20355.75Bearish
  10. DEMA 50362.21Bearish
  11. TEMA 10354.08Bearish
  12. TEMA 20354.17Bearish
  13. TEMA 50355.52Bearish
  14. MACD-2.68Bearish
  15. ADX17.55Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI35.69Neutral
  3. CCI-83.55Neutral
  4. ROC 9-0.83Bearish
  5. ROC 14-3.07Bearish
  6. ROC 25-2.52Bearish
  7. Stoch K14.46Oversold
  8. Stoch D14.49Oversold
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper369.58Neutral
  3. BB Middle360.36Neutral
  4. BB Lower351.15Neutral
  5. ATR4.10Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI21.35Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10359.06Bearish
  3. SMA 20362.28Bearish
  4. SMA 50365.59Bearish
  5. EMA 10358.36Bearish
  6. EMA 20360.78Bearish
  7. EMA 50357.81Bearish
  8. DEMA 10355.11Bearish
  9. DEMA 20358.16Bearish
  10. DEMA 50370.08Bearish
  11. TEMA 10353.90Bullish
  12. TEMA 20354.58Bearish
  13. TEMA 50364.45Bearish
  14. MACD-2.23Bearish
  15. ADX16.79Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI39.80Neutral
  3. CCI-109.25Oversold
  4. ROC 9-3.07Bearish
  5. ROC 14-3.41Bearish
  6. ROC 250.11Bullish
  7. Stoch K11.89Oversold
  8. Stoch D13.30Oversold
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper372.80Neutral
  3. BB Middle362.28Neutral
  4. BB Lower351.76Neutral
  5. ATR6.16Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI36.48Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10362.23Bearish
  3. SMA 20366.18Bearish
  4. SMA 50338.06Bullish
  5. EMA 10360.47Bearish
  6. EMA 20359.79Bearish
  7. EMA 50343.99Bullish
  8. DEMA 10357.78Bearish
  9. DEMA 20366.53Bearish
  10. DEMA 50368.29Bearish
  11. TEMA 10354.32Bearish
  12. TEMA 20359.38Bearish
  13. TEMA 50N/AN/A
  14. MACD3.79Bearish
  15. ADX37.70Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI48.07Neutral
  3. CCI-106.56Oversold
  4. ROC 9-3.50Bearish
  5. ROC 14-2.47Bearish
  6. ROC 25-1.73Bearish
  7. Stoch K22.90Neutral
  8. Stoch D25.53Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper385.02Neutral
  3. BB Middle366.18Neutral
  4. BB Lower347.34Neutral
  5. ATR10.83Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI52.40Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 10367.64Bearish
  3. SMA 20348.73Bullish
  4. SMA 50315.73Bullish
  5. SMA 100304.90Bullish
  6. SMA 200325.88Bullish
  7. EMA 10361.10Bearish
  8. EMA 20348.99Bullish
  9. EMA 50326.30Bullish
  10. EMA 100318.80Bullish
  11. EMA 200326.05Bullish
  12. DEMA 10369.86Bearish
  13. DEMA 20371.71Bearish
  14. DEMA 50346.25Bullish
  15. DEMA 100318.62Bullish
  16. DEMA 200308.26Bullish
  17. TEMA 10364.39Bearish
  18. TEMA 20376.75Bearish
  19. TEMA 50366.20Bearish
  20. TEMA 100335.02Bullish
  21. TEMA 200303.45Bullish
  22. MACD16.55Bearish
  23. ADX43.16Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI56.75Neutral
  3. CCI37.31Neutral
  4. ROC 147.13Bullish
  5. ROC 2524.66Bullish
  6. Stoch K52.73Neutral
  7. Stoch D58.69Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper400.63Neutral
  3. BB Middle348.73Neutral
  4. BB Lower296.84Neutral
  5. ATR17.94Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI77.36Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 20302.99Bullish
  3. SMA 50331.67Bullish
  4. EMA 20316.41Bullish
  5. EMA 50327.67Bullish
  6. DEMA 20316.44Bullish
  7. DEMA 50309.55Bullish
  8. TEMA 20331.37Bullish
  9. TEMA 50296.79Bullish
  10. MACD3.11Bullish
  11. ADX23.36Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI59.44Neutral
  3. CCI94.80Neutral
  4. ROC 1432.99Bullish
  5. ROC 256.38Bullish
  6. Stoch K86.89Overbought
  7. Stoch D74.86Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper354.51Overbought
  3. BB Middle302.99Neutral
  4. BB Lower251.48Neutral
  5. ATR28.54High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI84.38Overbought

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 6303.09Bullish
  3. SMA 12331.85Bullish
  4. SMA 24360.74Bearish
  5. EMA 6311.00Bullish
  6. EMA 12324.89Bullish
  7. EMA 24330.86Bullish
  8. DEMA 6300.26Bullish
  9. DEMA 12304.90Bullish
  10. DEMA 24342.27Bearish
  11. TEMA 6306.71Bullish
  12. TEMA 12289.47Bullish
  13. TEMA 24312.33Bullish
  14. MACD31.80Bearish
  15. ADX27.38Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI53.25Neutral
  3. CCI12.37Neutral
  4. ROC 252.11Bullish
  5. ROC 5034.08Bullish
  6. Stoch K29.90Neutral
  7. Stoch D53.81Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper462.61Neutral
  3. BB Middle358.28Neutral
  4. BB Lower253.95Neutral
  5. ATR57.84High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI50.59Neutral